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Summary The response of clonal subpopulations isolated from the RIF-1 mouse sarcoma to melphalan
treatment is independent of cell ploidy, whereas a clear relationship exists between ploidy and cell sensitivity
to CCNU treatment. In the present study RIF-1 clones have been exposed to nitrogen mustard, aniline
mustard and chlorambucil, and to nitrosoureas BCNU, MeCCNU and chlorozotocin, in order to evaluate
whether or not the different physiochemical and biological activities of these agents would affect the patterns
of drug sensitivity obtained for melphalan and CCNU. Irrespective of the different lipophilicities, transport
properties and chemical reactivities of the nitrogen mustards, RIF-1 clones showed the same pattern of
sensitivity as previously observed for melphalan. Similarly, RIF-1 clones when exposed to nitrosoureas
BCNU, MeCCNU and chlorozotocin, showed the same pattern of sensitivity as that obtained for CCNU
exposure. These data suggest (a) that the variation in the sensitivity of RIF-I clones to treatment by the
nitrogen mustards is unlikely to reflect differences in either membrane permeability or in drug transport and
(b) that the ploidy dependent nitrosourea responses shown by RIF-1 clones similarly do not reflect differences
in drug uptake.
It has previously been shown that clonal
subpopulations isolated from the RIF-I mouse
sarcoma differ markedly in their responses to in vitro
treatment with melphalan and CCNU (Reeve et al.,
1983b). No relationship was observed between
ploidy levels of RIF-1 clones and melphalan
sensitivity; for example the three tetraploid RIF-l
clones examined were of resistant, intermediate and
sensitive phenotypes and a diploid clone was of
intermediate sensitivity. However for CCNU
treatment clonal variation in sensitivity was
dependent upon ploidy, with diploid clones being
more sensitive to treatment than either tetraploid or
octoploid clones.
In the present study, we examine whether or not
the patterns of drug sensitivity observed for RIF-I
clones, when treated in vitro with melphalan and
CCNU, are also observed when these clones are
treated in vitro with other nitrogen mustards and
nitrosoureas. Drugs were selected on the basis of
their differing physicochemical and biological
activities in an attempt to evaluate the cellular
differences responsible for the diverse responses of
RIF-1 clones to these agents. For nitrosourea
treatment, clones were selected according to their
ploidy level; for treatment with nitrogen mustards,
clones were selected according to their relative
melphalan sensitivity.
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Materials and methods
Tumour cells
The RIF-1 tumour is an X-radiation induced
murine sarcoma and by means of flow cytometry
and chromosome analysis, has been shown to
contain both diploid and tetraploid subpopulations
of clonogenic tumour cells (Twentyman et al.,
1980).
Details of the in vitro cloning procedures used to
produce RIF-I clones of different ploidy are
described elsewhere (Reeve & Twentyman. 1983a).
The ploidy levels, as assessed by flow cytometry
(Reeve & Twentyman, 1983a), and the cytotoxic
drug sensitivities of RIF-I clones (Reeve et al.,
1983b) used in the present study are summarised in
Table I
In vitro drug treatment
Nitrosoureas Diploid (23,28) and tetraploid (16,20)
RIF-I clones growing in log phase monolayer
culture in 25cm2 tissue culture flasks, were exposed
to appropriate concentrations of BCNU, MeCCNU
and chlorozotocin (Dr Ven Nararayen, US
National Cancer Institute) for 1 h at 37°C. (CCNU
(Lundbeck Ltd., Luton) treatment was also
repeated in this study to confirm the patterns of
sensitivity previously shown by these clones (Table
I)). All nitrosoureas were dissolved in absolute
ethanol prior to use.
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Nitrogen mustards RIF-1 tetraploid clones 16, 19
and 20 growing in log phase culture were exposed
to appropriate concentrations of either nitrogen
mustard (Boots Co. Ltd., Nottingham, England)
aniline mustard and chlorambucil (Dr D. Wilman.
Chester Beatty Research Institute, London) for 1 h
at 37°C. (Melphalan (Burroughs Wellcome Co.
Ltd., London) was also included in this study to
confirm the patterns of sensitivity previously shown
by these clones (Table I)). Aniline mustard and
chlorambucil were dissolved in acid ethanol prior to
use; nitrogen mustard was first dissolved in distilled
water and was subsequently diluted to the required
concentration in acid ethanol.
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Table I Ploidy and cytotoxic drug sensitivity of
RIF-1 clonesa
Relative Relative
CCNU melphalan
Clone Ploidy sensitivity sensitivity
16 Tetraploid Resistant Sensitive
19 Tetraploid Resistant Intermediate
20 Tetraploid Resistant Resistant
28 Diploid Sensitive Intermediate
23 Diploid Sensitive Not done
aFrom Reeve et al., 1983b.
The medium used throughout was Eagle's
Minimal Essential Medium with Earle's Salts
supplemented with 10% new born calf serum
(Gibco Biocult) and antibiotics.
All drugs were prepared immediately before use
and added to the 5ml of medium overlying the cells
in a volume of 0.1 ml. As a control for each drug
under study 0.1 ml of the appropriate vehicle alone
was added to similar cultures. After treatment the
cells were rinsed twice and removed from the tissue
culture flasks using trypsin as previously described
(Twentyman et al., 1980), counted and various
numbers were plated into replicate petri dishes
containing medium. Cells were incubated for 13
days, fixed and stained with crystal violet. Colonies
containing at least 50 cells were counted with the
aid of a dissecting microscope.
Results
In vitro sensitivity ofRIF-] clones to selected
nitrosoureas
The data showing the responses of RIF-1 clones to
treatment with BCNU, MeCCNU and
chlorozotocin are shown in Figures 1-3. For all
three drugs, tetraploid clones 16 and 20 are
Figure 1 Cell survival curves of RIF-1 clones of
different ploidy values following in vitro treatment
with BCNU. Each point represents the survival value
obtained from a single experiment. (U) clone 20
(tetraploid); (0) clone 16 (tetraploid); (El) clone 28
(diploid); (0) clone 23 (diploid).
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Figure 2 As for Figure 1 except following in vitro
treatment with MeCCNU.
consistently more resistant to treatment than
diploid clones 23 and 28 (Similar data were also
obtained for CCNU treatment confirming our
previous findings).
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Figure 3 As for Figure 1 except following in vitro
treatment with chlorozotocin.
In vitro sensitivity ofRIF-] clones to the nitrogen
mustards
Figures 4, 5 and 6 show the responses of 3
tetraploid RIF-1 clones to treatment with nitrogen
mustard, chlorambucil and aniline mustard. It can
be seen that for all three drugs, clone 20 is
markedly more resistant to in vitro treatment, over
the dose range tested, than clones 16 and 19. (The
same pattern of sensitivity was also observed when
clones 16, 19 and 20 were treated with melphalan
confirming our previous findings).
Although clone 20 is relatively resistant to
treatment with nitrogen mustard itself, the shape of
its dose-response survival curve is the same as that
of clones 16 and 19; i.e. for all 3 clones there is an
exponential decline in survival with increasing dose
(Figure 4), as was obtained previously with
melphalan. However, for chlorambucil and aniline
mustard treatment, the survival curve for resistant
clone 20 is not exponential like that of clones 16
and 19, but at high doses reaches a constant value
(Figures 5, 6).
Figure 4 Cell survival curves of RIF- 1 clones
following in vitro treatment with Nitrogen Mustard.
Each point represents the survival value obtained from
a single experiment (0) clone 20 (tetraploid); (0)
clone 19 (tetraploid); (A) clone tetraploid).
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We have previously shown a wide variation in the
responses of RIF-I clonal subpopulations to both
Figure 5 As for Figure 4 except following in vitro
treatment with chlorambucil.
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Figure 6 As for Figure 4 except
treatment with Aniline Mustard.
following in vitro
in vivo and in vitro treatment with the alkylating
agents melphalan and CCNU (Reeve et al., 1983b).
For melphalan, drug sensitivity was independent of
the ploidy level of individual clones, but for CCNU
treatment a clear relationship existed between
ploidy and drug sensitivity with tetraploid and
octoploid clones being markedly more resistant to
drug treatment than diploid clones.
Several possible mechanisms of resistance to
alkylating agents have been described including (a)
reduced membrane permeability to the drug (e.g.
Goldenberg et al., 1970), (b) reduced drug transport
(e.g. Elliott & Ling, 1981; Redwood & Colvin,
1980), (c) the the presence of enzyme(s) either to
circumvent a specific metabolic block or to enhance
the capacity for repair of alkylated DNA (e.g.
Crathorn & Roberts, 1966; Roberts et al., 1968),
(d) increased cellular concentration of protective
agents such as thiols that spare critical target sites
from lethal injury by alkylation (e.g. Calcutt &
Connors, 1963; Goldenberg, 1969; Hirono, 1960).
In order to elucidate possible cellular mechanisms
involved in the patterns of drug sensitivity
described above we have exposed RIF-1 clones to
selected nitrosoureas and nitrogen mustards which
differ significantly in a variety of physicochemical
and biological activities. Thus the nitrosoureas were
selected on the basis of their different relative
alkylating activity versus carbamoylating activity1
and different lipophilicities2 (Wheeler et al., 1974;
Wheeler, 1976). The nitrogen mustards were
selected according to their different transport
properties (Goldenberg et al., 1970; Begleiter et al.,
1983; Begleiter & Goldenberg, 1983), lipophilicities
and chemical reactivities (Workman et al., 1976).
The results obtained in the present study show
that RIF-1 clones of different ploidy level, when
exposed in vitro to nitrosoureas, BCNU, MeCCNU
and chlorozotocin, show the same pattern of
sensitivity as that previously obtained for CCNU
exposure (Reeve et al., 1983b). This occurs despite
the marked differences shown by these drugs in
both relative alkylating/carbamoylating activity and
lipophilicity (Wheeler et al., 1974; Wheeler, 1976).
Evidence has been presented that BCNU and
CCNU are taken up into cells by passive diffusion
(Begleiter et al., 1977). This is also likely to be true
for the similarly lipophilic MeCCNU, but may not
necessarily apply to the more hydrophilic
chlorozotocin, which contains a sugar moeity.
Taken over all, it seems unlikely that differences in
drug uptake would account for the ploidy
dependent drug responses exhibited by RIF-1
clones to nitrosoureas.
As is the case with nitrosoureas, the RIF-1 clones
show the same pattern of sensitivity to the different
nitrogen mustards, i.e., aniline mustard,
chlorambucil and nitrogen mustard itself, as was
previously observed with melphalan (Reeve et al.,
1983b). This was true despite the differences in
lipophilicity, chemical reactivity (Workman et al.,
1976) and perhaps most important, differences in
cell transport properties of the nitrogen mustards.
If the comparative resistance of clone 20 to
melphalan is a result of reduced efficiency of the
amino acid transport system, as is seen with CHO
and L1210 resistant variants (Redwood & Colvin,
1980; Begleiter et al., 1983), one would not expect it
also to be resistant to nitrogen mustard, which is
actively transported by a different carrier
mechanism, the choline transport system,
(Goldenberg et al., 1971) or to the nitrogen
mustards known or predicted to enter the cell by
passive diffusion, respectively chlorambucil
(Begleiter & Goldenberg, 1983) and aniline
mustard. Thus differences in drug transport can
probably be ruled out.
'Nitrosoureas decompose at physiological conditions to
yield chloroethyldiazonium hydroxide moieties, which can
chloroethylate nucleophiles in nucleic acids, and
isocyanates which can react with proteins only be
carbamoylation.
2The lipophilicity of a drug measures its relative
solubility in water and lipid and is important in
determining the ease with which a drug crosses the cell
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Although the pattern of sensitivity shown by
RIF-1 clones in response to treatment with the
nitrogen mustards is the same throughout, the
shape of the dose-response curve for clone 20
clearly varies with the drug under study. For both
melphalan and nitrogen mustard there is an
exponential decline in survival with increasing dose;
for both aniline mustard and chlorambucil the dose
survival curves decrease to a constant value at high
doses. The shape of the dose survival curve for
clone 20 in response to treatment with aniline
mustard and chlorambucil is similar to that
obtained for chemotherapeutic agents which kill
cells in one portion ofthe cell cycle, i.e., phase specific
agents (Bruce et al., 1966). One possible
interpretation of our data is that the resistance of
clone 20 to aniline nEustard and chlorambucil
reflects the sensitivity of this clone to these agents
in only one part of the cell cycle.
On the basis of the results described here, it
seems likely that a common mechanism may pre-
dominantly govern the responses ofthe RIF-l clones
to the various nitrosoureas, while a different
common mechanism may determine their response
to the various nitrogen mustards. Drug uptake is
almost certainly not involved and thiol levels and
DNA repair capacity appear to us to be the most
likely possibilities. It is tempting to speculate, for
example, that the ploidy dependence of nitrosourea
may be the result of gene dosage for the repair
enzyme 06 methylguanine transferase, the suicide
enzyme thought to repair the initial chloroethyl
adduct which subsequently results in DNA cross-
linking (Erikson et al., 1980). We are currently
examining the rate of DNA repair, together with
levels of intercellular thiols.
A major problem in cancer therapy is the hetero-
geneous nature of human tumours and the role that
this heterogeneity plays in the existence within a
single neoplasm, of tumour cell populations with
differing susceptibilities to therapeutic agents.
Nitrosoureas, such as those used in the present
study, are used in the treatment of a number of
human tumours, with varying success. It is well
established that human tumours can be
heterogeneous with respect to chromosome number
and DNA content. Our findings suggest that
tumour cell ploidy may be an important factor in
determining the susceptibility of human tumour
cells to treatment with nitrosoureas.
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